flurbiprofen has been researched along with Arteriosclerosis in 2 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A multicentre controlled trial was conducted on 383 patients to compare the effectiveness of flurbiprofen (100 mg/day) and an ergot derivative in preventing cerebral infarction." | 9.05 | [Secondary prevention of cerebral infarction caused by atherosclerosis. 3-year comparison of flurbiprofen and an ergot derivative]. ( Dehen, H; Dordain, G; Doyon, F, 1984) |
| "A multicentre controlled trial was conducted on 383 patients to compare the effectiveness of flurbiprofen (100 mg/day) and an ergot derivative in preventing cerebral infarction." | 5.05 | [Secondary prevention of cerebral infarction caused by atherosclerosis. 3-year comparison of flurbiprofen and an ergot derivative]. ( Dehen, H; Dordain, G; Doyon, F, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dehen, H | 2 |
| Dordain, G | 1 |
| Doyon, F | 1 |
2 trials available for flurbiprofen and Arteriosclerosis
| Article | Year |
|---|---|
[Controlled trial of flurbiprofen (platelet anti-aggregant) in the secondary prevention of atherosclerotic cerebral infarcts].
Topics: Aged; Arteriosclerosis; Cerebral Infarction; Clinical Trials as Topic; Female; Flurbiprofen; Humans; | 1983 |
[Secondary prevention of cerebral infarction caused by atherosclerosis. 3-year comparison of flurbiprofen and an ergot derivative].
Topics: Arteriosclerosis; Cerebral Infarction; Clinical Trials as Topic; Ergot Alkaloids; Female; Flurbiprof | 1984 |